Mesabi Trust saw its IBD SmartSelect Composite Rating rise to 96 Tuesday, up from 94 the day before.
Discover The 3 Keys To Successful Stock Investing
The new rating shows the stock is outpacing 96% of all stocks when it comes to the most important stock-picking criteria.
Mesabi Trust broke out earlier, but has fallen back below the prior 26.80 entry from a consolidation. If a stock you're tracking breaks past a buy point then falls 7% or more below the original entry price, it's considered a failed base. It's best to wait for the stock to form a new consolidation and breakout. Also understand that the latest consolidation is a later-stage base, and those involve more risk. Understand that it's a thinly traded stock, with average daily dollar volume under $8 million. Less liquid stocks are more prone to large daily or weekly fluctuations since it takes fewer shares traded to move the share price significantly.
One weak spot is the company's 77 EPS Rating, which tracks quarterly and annual earnings-per-share growth. Look for that to improve to 80 or better to show it's in the top 20% of all stocks.
Its Accumulation/Distribution Rating of B shows moderate buying by institutional investors over the last 13 weeks.
In Q4, the company posted 28% earnings growth. Top line growth came in at 10%, down from 1,512% in the prior quarter. The company's next quarterly report is expected on or around Dec. 11.
Mesabi Trust holds the No. 2 rank among its peers in the Mining-Metal Ores industry group. Cameco is the No. 1-ranked stock within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
